Green Cures Botanical Stock Fundamentals
| GRCU Stock | USD 0.0001 0.0001 50.00% |
Green Cures Botanical fundamentals help investors to digest information that contributes to Green Cures' financial success or failures. It also enables traders to predict the movement of Green Pink Sheet. The fundamental analysis module provides a way to measure Green Cures' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Green Cures pink sheet.
Green |
Green Cures Botanical Company Profit Margin Analysis
Green Cures' Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.
Current Green Cures Profit Margin | 4.96 % |
Most of Green Cures' fundamental indicators, such as Profit Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Green Cures Botanical is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, Profit Margin indicator shows the amount of money the company makes from total sales or revenue. It can provide a good insight into companies in the same sector, as well as help to identify trends of a company from year to year.
| Competition |
Based on the latest financial disclosure, Green Cures Botanical has a Profit Margin of 4.9644%. This is 144.29% lower than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers—Specialty & Generic industry. The profit margin for all United States stocks is notably lower than that of the firm.
Green Cures Botanical Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Green Cures's current stock value. Our valuation model uses many indicators to compare Green Cures value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Green Cures competition to find correlations between indicators driving Green Cures's intrinsic value. More Info.Green Cures Botanical is one of the top stocks in return on equity category among its peers. It also is one of the top stocks in return on asset category among its peers reporting about 0.04 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Green Cures Botanical is roughly 23.75 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Green Cures' earnings, one of the primary drivers of an investment's value.Green Profit Margin Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Green Cures' direct or indirect competition against its Profit Margin to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Green Cures could also be used in its relative valuation, which is a method of valuing Green Cures by comparing valuation metrics of similar companies.Green Cures is currently under evaluation in profit margin category among its peers.
Green Fundamentals
| Return On Equity | 0.55 | |||
| Return On Asset | 0.023 | |||
| Profit Margin | 4.96 % | |||
| Operating Margin | 0.62 % | |||
| Current Valuation | 4.85 M | |||
| Price To Sales | 2.80 X | |||
| Revenue | 13.17 K | |||
| Gross Profit | 989.6 K | |||
| EBITDA | 861.7 K | |||
| Net Income | (1.09 M) | |||
| Cash And Equivalents | 80 K | |||
| Cash Per Share | 0.04 X | |||
| Total Debt | 3.1 M | |||
| Debt To Equity | 0.09 % | |||
| Current Ratio | 4.85 X | |||
| Book Value Per Share | (2.23) X | |||
| Cash Flow From Operations | (73.09 K) | |||
| Earnings Per Share | 3.15 X | |||
| Number Of Employees | 20 | |||
| Beta | 1.09 | |||
| Market Capitalization | 2.54 M | |||
| Total Asset | 406 | |||
| Retained Earnings | (1.58 M) | |||
| Working Capital | (539 K) | |||
| Current Liabilities | 539 K | |||
| Z Score | -22.03 | |||
| Net Asset | 406 |
About Green Cures Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Green Cures Botanical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Green Cures using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Green Cures Botanical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Green Cures Botanical Distribution Inc. operates various services and products in the medical marijuana and botanical industry. Green Cures Botanical Distribution Inc. is based in Inglewood, California. Green Cures operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 20 people.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Green Pink Sheet Analysis
When running Green Cures' price analysis, check to measure Green Cures' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Green Cures is operating at the current time. Most of Green Cures' value examination focuses on studying past and present price action to predict the probability of Green Cures' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Green Cures' price. Additionally, you may evaluate how the addition of Green Cures to your portfolios can decrease your overall portfolio volatility.